Boya Deng
155 North Nanjing Street
Shenyang, 110001, China
Shenyang, 110001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Neoadjuvant tislelizumab (anti-PD-1 antibody) plus chemotherapy in patients with advanced epithelial ovarian cancer: the exploratory NAIVE trial.
Journal: Signal transduction and targeted therapy
Published: September 19, 2025
CCDC88C, an O-GalNAc glycosylation substrate of GALNT6, drives breast cancer metastasis by promoting c-JUN-mediated CEMIP transcription.
Journal: Cancer cell international
Published: February 07, 2024
PLAC8 contributes to the malignant behaviors of cervical cancer cells by activating the SOX4-mediated AKT pathway.
Journal: Histochemistry and cell biology
Published: December 15, 2022
SHCBP1 contributes to the proliferation and self‑renewal of cervical cancer cells and activation of the NF‑κB signaling pathway through EIF5A.
Journal: Oncology letters
Published: September 08, 2022
Identification of neoantigen-specific T cells and their targets: implications for immunotherapy of head and neck squamous cell carcinoma.
Journal: Oncoimmunology
Published: September 12, 2018
Critical Role of Estrogen Receptor Alpha O-Glycosylation by N-Acetylgalactosaminyltransferase 6 (GALNT6) in Its Nuclear Localization in Breast Cancer Cells.
Journal: Neoplasia (New York, N.Y.)
Published: May 04, 2018
The era of immunogenomics/immunopharmacogenomics.
Journal: Journal of human genetics
Published: March 30, 2018
CD8 lymphocytes in tumors and nonsynonymous mutational load correlate with prognosis of bladder cancer patients treated with immune checkpoint inhibitors.
Journal: Cancer reports (Hoboken, N.J.)
Published: January 16, 2018
Similarity and difference in tumor-infiltrating lymphocytes in original tumor tissues and those of in vitro expanded populations in head and neck cancer.
Journal: Oncotarget
Published: November 11, 2017
miR-27b is upregulated in cervical carcinogenesis and promotes cell growth and invasion by regulating CDH11 and epithelial-mesenchymal transition.
Journal: Oncology reports
Published: October 02, 2015
MicroRNA-142-3p inhibits cell proliferation and invasion of cervical cancer cells by targeting FZD7.
MicroRNA-142-3p inhibits cell proliferation and invasion of cervical cancer cells by targeting FZD7.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: February 16, 2015
Last Updated: 09/26/2026